🔗 Share this article

Chancellor Reeves has revealed she is planning "specific steps to address household expense challenges" in the forthcoming financial statement.

During an interview with the BBC, she stated that lowering inflation is a joint responsibility of both the government and the central bank.

The United Kingdom's inflation rate is projected to be the most elevated among the Group of Seven advanced economies this year and next.

Potential Energy Cost Measures

Sources suggest the government could take action to reduce energy bills, for example by reducing the present 5% rate of value-added tax applied on energy supplies.

An additional possibility is to reduce some of the regulatory levies presently included in bills.

Fiscal Limitations and Analyst Expectations

The administration will receive the next draft from the independent fiscal watchdog, the Office for Budget Responsibility, on the start of the week, which will clarify how much room there is for such actions.

The expectation from the majority of analysts is that Reeves will have to declare higher taxes or spending cuts in order to fulfill her declared debt limits.

Earlier on the same day, estimates indicated there was a twenty-two billion pound shortfall for the chancellor to address, which is at the more modest range of projections.

"There's a collective responsibility between the central bank and the administration to bear down further on some of the sources of inflation," the Chancellor told reporters in the US capital, at the conferences of the IMF and World Bank.

Revenue Pledges and International Concerns

While a great deal of the attention has been on likely tax increases, the Treasury chief said the latest information from the OBR had not changed her commitment to election pledges not to increase tax levels on earnings tax, VAT or social security contributions.

She attributed an "uncertain world" with increasing international and commercial issues for the fiscal revenue measures, likely to be focused on those "most able to pay."

International Trade Tensions

Commenting on apprehensions about the UK's economic relations with China she said: "Our security interests always take priority."

Last week's statement by China to tighten trade restrictions on rare earths and other materials that are essential for high-technology production led US President the US President to suggest an additional 100% import tax on imports from China, raising the possibility of an all-out commercial conflict between the two largest economies.

The American finance chief called China's action "economic coercion" and "a global supply chain power grab."

Inquired about accepting the American proposal to join its dispute with China, the Chancellor said she was "extremely troubled" by Chinese actions and called on the Beijing authorities "not to put up barriers and restrict access."

She said the decision was "bad for the international commerce and generates additional obstacles."

"I believe there are sectors where we must address China, but there are also important chances to export to China's economy, including banking sector and other areas of the economy. We've got to maintain that balance correct."

The chancellor also affirmed she was cooperating with international partners "on our own essential resources strategy, so that we are more independent."

Health Service Drug Costs and Investment

Reeves also recognized that the price the National Health Service spends on medicines could go up as a consequence of current discussions with the US government and its pharmaceutical firms, in return for reduced taxes and funding.

Some of the world's largest pharmaceutical manufacturers have said in recent statements that they are either delaying or canceling projects in the UK, with some attributing the modest returns they are receiving.

Recently, the Science Minister said the cost the NHS pays for medicines would have to go up to prevent companies and pharmaceutical investment leaving the United Kingdom.

The Chancellor stated to media: "It has been observed because of the pricing regime, that clinical trials, recent pharmaceuticals have not been offered in the UK in the manner that they are in other continental states."

"The objective is to ensure that patients getting treatment from the NHS are able to obtain the finest life-saving treatments in the world. And so we are looking at all of that, and... looking to secure additional funding into Britain."